Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...
Custom Power Apps development services by Cynoteck delivering scalable low-code and no-code solutions to automate workflows, build custom apps, and accelerate digital transformation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results